Neil W. Peterson - 10 Jun 2024 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Issuer symbol
MMSI
Transactions as of
10 Jun 2024
Net transactions value
-$277,845
Form type
4
Filing time
12 Jun 2024, 13:28:20 UTC
Previous filing
08 Mar 2024
Next filing
07 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Options Exercise $336,000 +7,500 +51% $44.80 22,319 10 Jun 2024 Direct F1
transaction MMSI Common Stock, No Par Value Sale $613,845 -7,500 -34% $81.85 14,819 10 Jun 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -7,500 -100% $0.000000* 0 10 Jun 2024 Common Stock 7,500 $44.80 Direct F1, F3
holding MMSI Non-qualified stock options (right to buy) 20,000 10 Jun 2024 Common Stock 20,000 $54.40 Direct F4
holding MMSI Non-qualified stock options (right to buy) 25,000 10 Jun 2024 Common Stock 25,000 $68.33 Direct F5
holding MMSI Non-qualified stock options (right to buy) 13,576 10 Jun 2024 Common Stock 13,576 $70.58 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2024.
F2 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.325 to $82.185, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 Becomes exercisable in equal annual installments of 20% commencing 3/2/2019.
F4 Becomes exercisable in equal annual installments of 20% commencing 4/25/2020.
F5 Becomes exercisable in equal annual installments of 25% commencing 8/19/2022.
F6 Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.